Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome
- 24 February 2022
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 63 (9) , 1415-1423
Abstract
Background and Rationale: After acute myocardial infarction (AMI), fibroblast activation protein (FAP) upregulation exceeds the infarct region. We sought further insights into the physiologic relevance by correlating FAP-targeted PET with tissue characteristics from cardiac magnetic resonance (CMR) and functional outcome. Methods: Thirty-five patients underwent CMR, perfusion SPECT, and 68Ga-FAPI-46 PET/CT within 11 days after AMI. Infarct size was determined from SPECT by comparison to reference database. For PET, regional standardized uptake values (SUV) and isocontour volumes-of-interest (VOI) determined the extent of cardiac FAP upregulation (FAP-volume). CMR yielded functional parameters, area of injury (late gadolinium enhancement, LGE) and T1/T2 mapping. Follow-up was available from echocardiography or CMR after 139.5 (IQR 80.5-188.25) days (n = 14). Results: The area of FAP-upregulation was significantly larger than SPECT perfusion defect size (58±15 vs. 23±17%, pP = 0.07), whereas there was a significant inverse correlation with LVEF obtained at later follow-up (r=-0.58, P = 0.007). Conclusion: Early after AMI and reperfusion therapy, activation of fibroblasts markedly exceeds the hypoperfused infarct region and involves non-infarcted myocardium. The 68Ga-FAPI PET signal does not match regional myocardial tissue characteristics as defined by CMR, but it is predictive of the evolution of ventricular dysfunction. FAP-targeted imaging may provide a novel biomarker of left ventricular remodeling that is complementary to existing techniques.Keywords
This publication has 36 references indexed in Scilit:
- The Biological Basis for Cardiac Repair After Myocardial InfarctionCirculation Research, 2016
- Can Native T1 Mapping Differentiate between Healthy and Diffuse Diseased Myocardium in Clinical Routine Cardiac MR Imaging?PLOS ONE, 2016
- Cardiac FibrosisCirculation Research, 2016
- View from the heart: cardiac fibroblasts in development, scarring and regenerationDevelopment, 2016
- Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunitiesJournal of Molecular and Cellular Cardiology, 2016
- Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarctionJournal of Molecular and Cellular Cardiology, 2015
- Advances in Parametric Mapping With CMR ImagingJACC: Cardiovascular Imaging, 2013
- Direct T2 Quantification of Myocardial Edema in Acute Ischemic InjuryJACC: Cardiovascular Imaging, 2011
- Left Ventricular Remodeling After Myocardial InfarctionCirculation, 2000
- Evidence for Cardiomyopathy in Familial Diabetes MellitusJournal of Clinical Investigation, 1977